Rockwell Medical Inc (RMTI)
1.58
-0.05
(-3.07%)
USD |
NASDAQ |
May 03, 16:00
1.59
+0.01
(+0.63%)
Pre-Market: 20:00
Rockwell Medical Cash from Financing (Quarterly): -0.742M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.742M |
| September 30, 2023 | 12.84M |
| June 30, 2023 | -0.13M |
| March 31, 2023 | -0.631M |
| December 31, 2022 | -5.984M |
| September 30, 2022 | -2.002M |
| June 30, 2022 | 26.82M |
| March 31, 2022 | -2.687M |
| December 31, 2021 | -1.624M |
| September 30, 2021 | -0.549M |
| June 30, 2021 | -0.006M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.001M |
| September 30, 2020 | 32.96M |
| June 30, 2020 | 0.80M |
| March 31, 2020 | 29.56M |
| December 31, 2019 | 2.502M |
| September 30, 2019 | 0.3206M |
| June 30, 2019 | 18.21M |
| March 31, 2019 | 0.0525M |
| December 31, 2018 | 22.01M |
| September 30, 2018 | -0.002M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.0075M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1161M |
| June 30, 2017 | -2.287M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0029M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.0772M |
| December 31, 2015 | -1.708M |
| September 30, 2015 | 0.0233M |
| June 30, 2015 | 0.6332M |
| March 31, 2015 | 0.9189M |
| December 31, 2014 | 56.40M |
| September 30, 2014 | 0.0286M |
| June 30, 2014 | 0.5671M |
| March 31, 2014 | 1.475M |
| December 31, 2013 | 0.9709M |
| September 30, 2013 | 0.1327M |
| June 30, 2013 | 56.86M |
| March 31, 2013 | 12.52M |
| December 31, 2012 | 0.2468M |
| September 30, 2012 | 0.1972M |
| June 30, 2012 | 1.467M |
| March 31, 2012 | 16.31M |
| December 31, 2011 | 0.9021M |
| September 30, 2011 | 1.538M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.984M
Minimum
Dec 2022
32.96M
Maximum
Sep 2020
5.772M
Average
-0.001M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.999M |
| Oragenics Inc | -0.1806M |
| Alpine Immune Sciences Inc | 156.61M |
| Corvus Pharmaceuticals Inc | 0.00 |
| MAIA Biotechnology Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.043M |
| Cash from Investing (Quarterly) | 2.008M |
| Free Cash Flow | -9.696M |
| Free Cash Flow Per Share (Quarterly) | -0.003 |
| Free Cash Flow to Equity (Quarterly) | 0.827M |
| Free Cash Flow Yield | -26.37% |